The global oral solid dosage (OSD) contract manufacturing market was valued at USD 36.50 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 5.97% from 2024 to 2030. The market's growth is fueled by advancements in drug delivery technologies, including targeted drug delivery and sustained-release dosage forms. Additionally, contract development manufacturing...
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian